“Based on the available data on mutations in the spike protein of the omicron variant, there is reason to believe that the anti-epidemic efficacy of the Epivackoron and Epivackoron-N vaccines will be comparable to that for the delta variant,” TASS reports.

According to data as of November 28, 33,548 cases of coronavirus were registered in Russia per day.

In total, 9,570,373 cases of COVID-19 have been confirmed in the country since the beginning of the epidemic. 

Kirill Masliev, Candidate of Medical Sciences, Head of Preventive Medicine at EMC, founder of the Heroes Foundation for the Support of Medical Workers, spoke to the Komsomolskaya Pravda radio about the recommendations of the Ministry of Health on the treatment of COVID-19.